Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study

BackgroundAdvanced hepatocellular carcinoma (HCC) is characterized as symptomatic tumors [performance status (PS) score of 1-2], vascular invasion and extrahepatic spread, but patients with PS1 alone may be eliminated from this stage. Although liver resection is used for liver-confined HCC, its role...

Full description

Bibliographic Details
Main Authors:	Tingting Bai, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Hui Chen, Jun Zhu, Tenghui Han, Yang Bai, Yanju Lou, Yongchao Zhang, Man Yang, Luo Zuo, Jiahao Fan, Xing Chen, Jia Jia, Wenbin Wu, Weirong Ren, Yejing Zhu, Shouzheng Ma, Fenghua Xu, Yuxin Tang, Xilin Du, Junlong Zhao, Jing Li, Xingshun Qi, Ying Han, Dongfeng Chen, Lei Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma liver resection performance status overall survival prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1170923/full

Similar Items

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study
by: Yejing Zhu, et al.
Published: (2023-01-01)

Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma
by: Jun Zhu, et al.
Published: (2022-07-01)

Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral Activity
by: Junlong Zhao, et al.
Published: (2023-02-01)

Implications of Laboratory Tests in Disease Grading and Death Risk Stratification of COVID-19: A Retrospective Study in Wuhan, China
by: Yang Bai, et al.
Published: (2021-02-01)

Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis.
by: Lei Liu, et al.
Published: (2014-01-01)

Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis
by: Yongchao Zhang, et al.
Published: (2021-01-01)

Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients
by: Mai R, et al.
Published: (2019-10-01)

Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients
by: Po-Jung Hsu, et al.
Published: (2021-10-01)

Fontan Liver Lesions: Not Always HCC
by: Christiane Haeffele, MD, MPH, et al.
Published: (2019-08-01)

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
by: Lei Liu, et al.
Published: (2022-01-01)

Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus
by: Lei Huo, et al.
Published: (2019-03-01)

Ablative Therapy in Non-HCC Liver Malignancy
by: Tyler P. Robinson, et al.
Published: (2023-02-01)

Viral integration drives multifocal HCC during the occult HBV infection
by: Xiao-Ping Chen, et al.
Published: (2019-06-01)

LiverHccSeg: A publicly available multiphasic MRI dataset with liver and HCC tumor segmentations and inter-rater agreement analysis
by: Moritz Gross, et al.
Published: (2023-12-01)

Age-Associated Risk of Liver-Related Adverse Drug Reactions
by: Yan-zhong Han, et al.
Published: (2022-03-01)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
by: Xiao-Ping Chen, et al.
Published: (2019-12-01)

Qualitative and Quantitative Assessment of Enhancement and Washout Characteristics of HCC and non HCC Hypervascular Liver Tumours
by: Prerna Garg, et al.
Published: (2018-02-01)

Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis
by: Jing Li, et al.
Published: (2018-01-01)

NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC)
by: Eugenia Bezzecchi, et al.
Published: (2020-12-01)

Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
by: Laura Crocetti, et al.
Published: (2021-11-01)

Liver cirrhosis in a patient with hepatic hereditary hemorrhagic telangiectasia and Budd–Chiari syndrome: a case report
by: Bai-Guo Xu, et al.
Published: (2020-06-01)

LiverWiki: a wiki-based database for human liver
by: Tao Chen, et al.
Published: (2017-10-01)

The Treatment Effect of Liver Transplantation versus Liver Resection for HCC: A Review and Future Perspectives
by: Berend R. Beumer, et al.
Published: (2021-07-01)

Progression of liver cirrhosis to HCC: an application of hidden Markov model
by: Serio Gabriella, et al.
Published: (2011-04-01)

AFP ratio predicts HCC recurrence after liver transplantation.
by: Christine Koch, et al.
Published: (2020-01-01)

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
by: Muhammad Sajid, et al.
Published: (2022-05-01)

The versatility of macrophage heterogeneity in liver fibrosis
by: Chun-Chen Gao, et al.
Published: (2022-08-01)

The Effects of Liver Function Damage after Thermal Ablation on the Prognosis of HCC Patients and Its Prediction
by: Yan Zhou, Jianmin Ding, Fengmei Wang, Zhengyi Qin, Yandong Wang, Hongyu Zhou, Xiang Jing
Published: (2021-06-01)

Outcomes and Patient Selection in Laparoscopic vs. Open Liver Resection for HCC and Colorectal Cancer Liver Metastasis
by: Jurgis Alvikas, et al.
Published: (2023-02-01)

Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCC
by: Becker Diana, et al.
Published: (2012-08-01)

Application of the Multi-Omics Liquid Biopsy Method M2P-HCC in Early Liver Cancer Screening for High-Risk Individuals with Hepatitis B-Related Liver Cancer
by: Xian Yu, et al.
Published: (2023-07-01)

Standard Liver Volume-Predicting Formulae Derived From Normal Liver Volume in Children Under 18 Years of Age
by: Xintian Yang, et al.
Published: (2021-02-01)

Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting
by: Maria Cristina Bonferoni, et al.
Published: (2020-04-01)

Hepatocellular Carcinoma (HCC) Surveillance – Comprehensive Management in Liver Cirrhosis Patients
by: Rino Alvani Gani
Published: (2017-12-01)

Editorial: Treatment and prognostic assessment of liver cirrhosis and its complications
by: Feifei Lu, et al.
Published: (2024-01-01)

Significant CircRNAs in liver cancer stem cell exosomes: mediator of malignant propagation in liver cancer?
by: Tao Han, et al.
Published: (2023-12-01)

Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease Model
by: Adam M. Passman, et al.
Published: (2021-09-01)

The ALBI score: From liver function in patients with HCC to a general measure of liver functionKey points
by: Hidenori Toyoda, et al.
Published: (2022-10-01)

Application of artificial intelligence in a real-world research for predicting the risk of liver metastasis in T1 colorectal cancer
by: Tenghui Han, et al.
Published: (2022-01-01)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
by: Qingling Chen, et al.
Published: (2023-09-01)